Annual FCF
$6.55 M
+$15.59 M+172.50%
31 December 2023
Summary:
Organogenesis Holdings annual free cash flow is currently $6.55 million, with the most recent change of +$15.59 million (+172.50%) on 31 December 2023. During the last 3 years, it has risen by +$18.77 million (+153.66%). ORGO annual FCF is now -78.69% below its all-time high of $30.76 million, reached on 31 December 2021.ORGO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$6.13 M
+$3.27 M+114.35%
30 September 2024
Summary:
Organogenesis Holdings quarterly free cash flow is currently $6.13 million, with the most recent change of +$3.27 million (+114.35%) on 30 September 2024. Over the past year, it has dropped by -$4.63 million (-43.04%). ORGO quarterly FCF is now -65.58% below its all-time high of $17.80 million, reached on 31 December 2020.ORGO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$3.89 M
-$4.63 M-54.34%
30 September 2024
Summary:
Organogenesis Holdings TTM free cash flow is currently $3.89 million, with the most recent change of -$4.63 million (-54.34%) on 30 September 2024. Over the past year, it has increased by +$7.48 million (+208.27%). ORGO TTM FCF is now -89.14% below its all-time high of $35.83 million, reached on 30 September 2021.ORGO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +172.5% | -43.0% | +208.3% |
| 3 y3 years | +153.7% | -45.0% | -89.1% |
| 5 y5 years | +110.5% | +191.1% | +108.2% |
ORGO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -78.7% | +153.7% | -51.8% | +148.5% | -89.1% | +120.2% |
| 5 y | 5 years | -78.7% | +110.5% | -65.6% | +128.5% | -89.1% | +107.6% |
| alltime | all time | -78.7% | +110.5% | -65.6% | +125.6% | -89.1% | +105.7% |
Organogenesis Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.13 M(+114.3%) | $3.89 M(-54.3%) |
| June 2024 | - | $2.86 M(-123.1%) | $8.52 M(+25.1%) |
| Mar 2024 | - | -$12.38 M(-269.9%) | $6.81 M(+3.9%) |
| Dec 2023 | $6.55 M(-172.5%) | $7.29 M(-32.2%) | $6.55 M(-282.4%) |
| Sept 2023 | - | $10.76 M(+837.7%) | -$3.59 M(-81.4%) |
| June 2023 | - | $1.15 M(-109.1%) | -$19.30 M(+17.5%) |
| Mar 2023 | - | -$12.64 M(+342.5%) | -$16.42 M(+81.6%) |
| Dec 2022 | -$9.04 M(-129.4%) | -$2.86 M(-42.3%) | -$9.04 M(-238.3%) |
| Sept 2022 | - | -$4.95 M(-222.9%) | $6.54 M(-71.1%) |
| June 2022 | - | $4.03 M(-176.5%) | $22.63 M(-28.7%) |
| Mar 2022 | - | -$5.26 M(-141.4%) | $31.75 M(+3.2%) |
| Dec 2021 | $30.76 M(-351.9%) | $12.72 M(+14.1%) | $30.76 M(-14.2%) |
| Sept 2021 | - | $11.15 M(-15.2%) | $35.83 M(+29.3%) |
| June 2021 | - | $13.15 M(-310.1%) | $27.71 M(+806.3%) |
| Mar 2021 | - | -$6.26 M(-135.2%) | $3.06 M(-125.0%) |
| Dec 2020 | -$12.21 M | $17.80 M(+489.3%) | -$12.21 M(-69.4%) |
| Sept 2020 | - | $3.02 M(-126.3%) | -$39.87 M(-19.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$11.50 M(-46.6%) | -$49.62 M(-3.5%) |
| Mar 2020 | - | -$21.53 M(+118.3%) | -$51.41 M(+29.3%) |
| Dec 2019 | -$39.76 M(-36.4%) | -$9.86 M(+46.5%) | -$39.76 M(-16.6%) |
| Sept 2019 | - | -$6.73 M(-49.4%) | -$47.67 M(-26.5%) |
| June 2019 | - | -$13.30 M(+34.7%) | -$64.87 M(-4.4%) |
| Mar 2019 | - | -$9.88 M(-44.4%) | -$67.84 M(+8.6%) |
| Dec 2018 | -$62.49 M(+955.8%) | -$17.77 M(-25.8%) | -$62.49 M(+30.9%) |
| Sept 2018 | - | -$23.93 M(+47.1%) | -$47.72 M(+99.2%) |
| June 2018 | - | -$16.27 M(+259.9%) | -$23.96 M(+203.8%) |
| Mar 2018 | - | -$4.52 M(+50.8%) | -$7.89 M(+125.8%) |
| Dec 2017 | -$5.92 M(-5.0%) | -$3.00 M(+1677.2%) | -$3.49 M(-34.6%) |
| Sept 2017 | - | -$168.70 K(-15.5%) | -$5.34 M(+2.8%) |
| June 2017 | - | -$199.70 K(+58.1%) | -$5.20 M(+4.0%) |
| Mar 2017 | - | -$126.30 K(-97.4%) | -$5.00 M(+2.6%) |
| Dec 2016 | -$6.23 M | -$4.85 M(>+9900.0%) | -$4.87 M(>+9900.0%) |
| Sept 2016 | - | -$24.50 K(<-9900.0%) | -$24.50 K(<-9900.0%) |
| June 2016 | - | $200.00(-200.0%) | $0.00(-100.0%) |
| Mar 2016 | - | -$200.00 | -$200.00 |
FAQ
- What is Organogenesis Holdings annual free cash flow?
- What is the all time high annual FCF for Organogenesis Holdings?
- What is Organogenesis Holdings annual FCF year-on-year change?
- What is Organogenesis Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly FCF year-on-year change?
- What is Organogenesis Holdings TTM free cash flow?
- What is the all time high TTM FCF for Organogenesis Holdings?
- What is Organogenesis Holdings TTM FCF year-on-year change?
What is Organogenesis Holdings annual free cash flow?
The current annual FCF of ORGO is $6.55 M
What is the all time high annual FCF for Organogenesis Holdings?
Organogenesis Holdings all-time high annual free cash flow is $30.76 M
What is Organogenesis Holdings annual FCF year-on-year change?
Over the past year, ORGO annual free cash flow has changed by +$15.59 M (+172.50%)
What is Organogenesis Holdings quarterly free cash flow?
The current quarterly FCF of ORGO is $6.13 M
What is the all time high quarterly FCF for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly free cash flow is $17.80 M
What is Organogenesis Holdings quarterly FCF year-on-year change?
Over the past year, ORGO quarterly free cash flow has changed by -$4.63 M (-43.04%)
What is Organogenesis Holdings TTM free cash flow?
The current TTM FCF of ORGO is $3.89 M
What is the all time high TTM FCF for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM free cash flow is $35.83 M
What is Organogenesis Holdings TTM FCF year-on-year change?
Over the past year, ORGO TTM free cash flow has changed by +$7.48 M (+208.27%)